Baker Bros. Advisors LP Legend Biotech Corp Transaction History

Baker Bros. Advisors LP

8 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2022 Aug 15, 2022	SELL	$33.54 - $55.0 $38.6 Million - $63.4 Million	-1,152,341 Reduced 57.36%	856,658 $47.1 Million
Q1 2022 May 16, 2022	SELL	$31.02 - $48.18 $14.9 Million - $23.1 Million	-480,004 Reduced 19.28%	2,008,999 $73 Million
Q4 2021 Feb 14, 2022	BUY	$41.14 - $56.98 $5.14 Million - $7.12 Million	125,000 Added 5.29%	2,489,003 $116 Million
Q3 2021 Nov 15, 2021	BUY	$35.31 - $50.56 $24.7 Million - $35.4 Million	699,469 Added 42.02%	2,364,003 $120 Million
Q2 2021 Aug 16, 2021	BUY	$25.8 - $41.09 $40 Million - $63.6 Million	1,548,908 Added 1339.58%	1,664,534 $68.3 Million
Q4 2020 Feb 16, 2021	SELL	$25.8 - $32.39 $324,409 - $407,271	-12,574 Reduced 9.81%	115,626 $3.26 Million
Q3 2020 Nov 16, 2020	SELL	$27.5 - $39.61 $187,000 - $269,348	-6,800 Reduced 5.04%	128,200 $3.96 Million
Q2 2020 Aug 14, 2020	BUY	$36.1 - $42.56 $4.87 Million - $5.75 Million	135,000 New	135,000 $5.75 Million

205

74.5M

371K

387K

Ticker LEGN
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 167,403,008
Market Cap $6.7B
Description
Legend Biotech Corporation, a clinical-stage biopharmaceutical company, through its subsidiaries, engages in the discovery and development of novel cell therapies for oncology and other indications in the United States, China, and internationally. Its lead product candidate, LCAR- B38M, is a chimeric antigen receptor for the treatment of multipl...

Get notified when there are updates to the investment portfolio of Baker Bros. Advisors LP, based on Form 13F filings with the SEC.

Stay updated on Baker Bros. Advisors LP with notifications on news.